Leukaemia Foundation congratulates newly appointed Health Minister and welcomes collaboration to ensure no Australian loses their life to blood cancer by 2035
- Media releases
Author: Michael Yare
World Blood Cancer Day…a timely reminder to check for signs and symptoms of Australia’s second most diagnosed cancer!
- Media releases
Terry’s ups and downs during 20 years living with CML
Terry Robson-Petch has been living with CML for 20 years.
- Chronic myeloid leukaemia
Expert series interview: Dr Naranie Shanmuganathan on CML
The greatest unmet need in CML is the ability to predict outcomes at the time of diagnosis according to Dr Naranie Shanmuganathan, a consultant haematologist at Royal Adelaide Hospital and SA Pathology.
- Chronic myeloid leukaemia
- Interviews with experts
- Research
From dialysis to blood cancer: Robert’s story
Northern Territory local Robert Smith had been living on dialysis for 12 years when he was diagnosed with myeloma. Robert discusses the importance that the support of his wife, Jo was in his journey. He takes us through his story — from diagnosis, to what it was like to travel to Adelaide for life-saving treatment and his recovery.
- Myeloma
Leukaemia Foundation calls for greater awareness of myeloma among Australians as incidence rates set to more than double by 2035
- Media releases
Regina’s new life is about making memories with her girls
The week before Regina Batten’s wedding, in August 2017, she was diagnosed with AML. She had just celebrated her 30th birthday and was about to marry the father of her three children.
- Acute myeloid leukaemia
Expert Series: Dr Cameron Curley on transplantation and CAR-T therapy
Dr Cameron Curley describes CAR T-cell therapy as “arguably the biggest breakthrough in the treatment of many blood cancers in the last decade”.
- Acute myeloid leukaemia
- Interviews with experts
Diagnosed the night before her wedding: Katherine’s story
- Hodgkin lymphoma
Innovative new international trial for relapsed paediatric ALL opens soon
A clinical trial, due to open in mid-2022, will give young people access to two promising new ALL drugs.
- Acute lymphoblastic leukaemia
- Clinical trials
- Research
- “Live life to the fullest”: Josh Gourlay opens up about returning to work and new beginnings after blood cancer
- Advocacy news – July 2024
- Talking Blood Cancer: Estate planning and medical directives
- Running for a Cause: Cal Gates’ Journey from Newcastle to Sydney on foot in one weekend
- World Blood Cancer Day 2024